Li, Hengchao
Liu, Xiaohui
Jiang, Shuheng
Zhou, Xinwen
Yao, Lie
Di, Yang
Jiang, Yongjian
Gu, Jichun
Mao, Yishen
Li, Ji
Jin, Chen
Yang, Pengyuan
Fu, Deliang
Funding for this research was provided by:
National Natural Science Foundation of China (No.81472221, No.81772566, No.81201896, No.31800691, No.21874026)
Article History
Received: 10 September 2019
Revised: 27 April 2020
Accepted: 21 May 2020
First Online: 30 June 2020
Ethics approval and consent to participate
: This study was performed in accordance with the Declaration of Helsinki. All animal experiments were performed in accordance with the criteria outlined in the “Guide for the Care and Use of Laboratory Animals” prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication 86-23, revised 1985). All manipulations were approved by the Research Ethics Committee of Huashan Hospital, Fudan University, and all the patients were provided with written informed consent before enrolment.
: Not applicable.
: Data are available upon request.
: The authors declare no competing interests.
: This work was supported by grants from the Shanghai Municipal Planning Commission of Science and Research Fund (201840192), the National Natural Science Foundation of China (Nos. 81472221, 81772566, 81201896, 31800691 and 21874026), the Chinesisch-Deutsche Kooperationsgruppe: Precision Medicine in Pancreatic Cancer (GZ1456), the Special Project on Precision Medicine under the National Key R&D Program (SQ2017YFSF090210), the National Key Research and Development Program of China (2017YFA0505100) and Clinical key projects of the National Health and Family Planning (Oncology 2013–2015).